Skip to main content

Development of Eppin Pharma's technology with in vivo toxicology studies

Printer-friendly versionPrinter-friendly versionSend by emailSend by email
Award date: 
Dec 9, 2014
Award amount: 
$75,000
Organization name: 
Eppin Pharma Inc
Principal Investigator: 
O'Rand, Michael G
Grant program category: 
Business Financing
Grant program name: 
Small Business Research Loan
Region: 
Research Triangle

This project will provide Eppin Pharma with the means to develop the company's business plan and website as well as conduct the first in vivo test of our lead compound for toxicology.

Fiscal year: 
2015